Close Menu

The FDA has a new Transparency Blog, as Bertalan Meskó points out, that will run for the next six months to "discuss various ways in which the Food and Drug Administration (FDA) could provide information to the public about what FDA is doing, the bases for FDA's decisions, and the processes used to make agency decisions." The first question the

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.